BioCentury
ARTICLE | Company News

uniQure B.V., Xenon deal

February 11, 2013 8:00 AM UTC

Xenon said it received an undisclosed milestone payment from uniQure under a 2001 deal granting Amsterdam Molecular Therapeutics Holding N.V., which dissolved into uniQure last year, access to its IP...